Zomedica Corp. logo
Zomedica Corp. ZOM

Quarterly report 2026-Q1
added 05-06-2026

report update icon

Zomedica Corp. Interest Expense 2011-2026 | ZOM

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Zomedica Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-144 K 10 K 175 K 1 K 6 K 732 18.3 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
175 K -144 K 9.58 K

Quarterly Interest Expense Zomedica Corp.

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-26 K -13 K -39 K -44 K - -111 K 52 K 84 K - 2.2 M 62 K 50 K - -5 K 1 K -1 K - 1 K 505 K 55 K - - - 651 - 18.3 K 12.2 K 6.17 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.2 M -111 K 140 K

Interest Expense of other stocks in the Drug manufacturers industry

Issuer Interest Expense Price % 24h Market Cap Country
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
496 K $ 5.47 11.18 % $ 81.3 M usaUSA
Evoke Pharma Evoke Pharma
EVOK
501 K - - $ 36.6 M usaUSA
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
134 K - 7.5 % $ 6.35 M usaUSA
DURECT Corporation DURECT Corporation
DRRX
2.4 M - - $ 50.1 M usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
4.92 K - 0.86 % $ 117 M usaUSA
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
-27.9 M - - $ 754 M usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
1.42 M - 10.11 % $ 58.2 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
10.2 M - - $ 142 M usaUSA
Cronos Group Cronos Group
CRON
-241 K $ 2.63 -4.01 % $ 1.01 B canadaCanada
Harrow Health Harrow Health
HROW
47 K $ 31.21 1.13 % $ 1.15 B usaUSA
Athenex Athenex
ATNX
25.8 M - -23.39 % $ 1.76 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
13 M - - $ 2.06 B franceFrance
Catalent Catalent
CTLT
-4 M - - $ 11.5 B usaUSA
HEXO Corp. HEXO Corp.
HEXO
20.1 M - 2.45 % $ 38.1 M canadaCanada
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
4.04 M - -39.89 % $ 27.7 M usaUSA
Endo International plc Endo International plc
ENDP
350 M - - $ 28.9 M irlandaIrlanda
Organogenesis Holdings Organogenesis Holdings
ORGO
-5 K $ 2.41 -6.95 % $ 305 M usaUSA
Bausch Health Companies Bausch Health Companies
BHC
-28 M $ 5.42 -0.55 % $ 1.98 B canadaCanada
Pacira BioSciences Pacira BioSciences
PCRX
-373 K $ 22.64 -3.78 % $ 1.05 B usaUSA
Solid Biosciences Solid Biosciences
SLDB
824 K $ 6.92 -9.31 % $ 606 M usaUSA
Canopy Growth Corporation Canopy Growth Corporation
CGC
74.6 M $ 1.04 -2.8 % $ 112 M canadaCanada
Tilray Tilray
TLRY
46.6 M $ 5.32 -3.27 % $ 3.29 B canadaCanada
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
-10 K $ 1.09 -7.63 % $ 1.35 M usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
152 K - - $ 33.6 M usaUSA
Lannett Company Lannett Company
LCI
58 M - 1.15 % $ 7.11 M usaUSA
Evolus Evolus
EOLS
-539 K $ 6.5 -1.22 % $ 419 M usaUSA
Sundial Growers Sundial Growers
SNDL
81 K $ 1.43 -2.05 % $ 3.37 M canadaCanada
Veru Veru
VERU
768 K $ 2.11 0.96 % $ 30.9 M usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
87.9 M $ 7.94 -3.29 % $ 407 M usaUSA
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
12 K - - $ 193 M canadaCanada
ProPhase Labs ProPhase Labs
PRPH
764 K - - $ 5.07 M usaUSA
Radius Health Radius Health
RDUS
18.3 M - - $ 1.42 B usaUSA
cbdMD cbdMD
YCBD
34.3 K $ 0.77 -6.44 % $ 3.1 M usaUSA
Assertio Holdings Assertio Holdings
ASRT
2.78 M $ 23.32 - $ 149 M usaUSA
PetIQ PetIQ
PETQ
38.3 M - 1.64 % $ 400 M usaUSA
Relmada Therapeutics Relmada Therapeutics
RLMD
5.15 M $ 6.9 -7.01 % $ 272 M usaUSA
Recro Pharma Recro Pharma
REPH
9.96 M - -4.76 % $ 65.3 M usaUSA
OptiNose OptiNose
OPTN
19.5 M - - $ 1.08 B usaUSA
SCYNEXIS SCYNEXIS
SCYX
3.13 M $ 0.74 -4.0 % $ 37 M usaUSA
Viatris Viatris
VTRS
471 M $ 16.48 -4.52 % $ 19.2 B usaUSA
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
27 K - - $ 55.5 M usaUSA
Rockwell Medical Rockwell Medical
RMTI
-623 K $ 0.79 -0.55 % $ 28.4 M usaUSA
Tricida Tricida
TCDA
17.6 M - - $ 3.25 M usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
27.3 K $ 1.04 -16.13 % $ 4.46 M chinaChina
TherapeuticsMD TherapeuticsMD
TXMD
300 K $ 2.0 0.5 % $ 23.1 M usaUSA